脑膜炎奈瑟菌血清群 A 和 C 疾病的临床试验
总计1693个结果
-
Merck Sharp & Dohme LLC撤销
-
Bristol-Myers Squibb完全的
-
Janssen Pharmaceutica N.V., Belgium完全的
-
University of Missouri, Kansas CityReliant Pharmaceuticals; Saint Luke's Health System Foundation; Truman Medical Center撤销
-
Kaohsiung Medical University Chung-Ho Memorial...完全的
-
Nanogen Pharmaceutical Biotechnology Joint Stock...完全的
-
Debiopharm International SA终止
-
Bristol-Myers SquibbBasel Institute of Clinical Epidemiology (BICE)完全的
-
Bristol-Myers Squibb完全的
-
Vertex Pharmaceuticals Incorporated终止
-
Merck Sharp & Dohme LLC完全的
-
Mitsubishi Tanabe Pharma Corporation完全的
-
ANRS, Emerging Infectious DiseasesInstitut Pasteur; National Hepatology & Tropical Medicine Research Institute撤销
-
Vertex Pharmaceuticals Incorporated完全的
-
University of ManitobaRoche Pharma AG完全的
-
Dr. Nadia AbdelAaty AbdelKader终止
-
Gilead Sciences完全的
-
National Taiwan University HospitalNational Science Council, Taiwan; Department of Health, Executive Yuan, R.O.C. (Taiwan)未知
-
Weill Medical College of Cornell UniversityNational Institute of Allergy and Infectious Diseases (NIAID)终止
-
Azienda Ospedaliera di PadovaUniversity of Padova; Regione Veneto完全的
-
AbbVie完全的
-
VA Office of Research and DevelopmentGlaxoSmithKline完全的
-
Beth Israel Medical Center终止
-
Debiopharm International SA完全的
-
Alios Biopharma Inc.完全的
-
AbbVieCato Research; IST GmbH, Germany完全的
-
AbbVieIST GmbH, Germany完全的
-
Bristol-Myers Squibb完全的
-
Foundation for Liver Research完全的丙型肝炎 | 免疫学 | 肝 | Regulation荷兰
-
Debiopharm International SA终止
-
NovartisHuman Genome Sciences Inc.完全的